Viewing Study NCT06232434

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:18 AM

Ignite Modification Date: 2025-12-27 @ 11:16 PM

Study NCT ID: NCT06232434

Status: RECRUITING

Last Update Posted: 2025-06-22

First Post: 2024-01-08

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: An Open Prospective Randomized Clinical Study of the Effectiveness, Tolerability and Safety of a Single Intraperitoneal Use of the Drug "Prospidelong, Powder for the Preparation of a Gel for Topical Use, 1000 mg in Vials, Package No. 1" in Patients With Disseminated Gastric Cancer, Phase I-II

Sponsor: Research Institute for Physical Chemical Problems of the Belarusian State University

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module